Imugene Limited — News

$0.07 USD

$0.01 (7.69%)

Volume: 50K
Average Volume: 24.74K
Market Capitalization: $29.12M
P/E Ratio: -0.37
Dividend Yield: 0.00%
Price Target

Year High: $0.31
Year Low: $0.06
Day High: —
Day Low: —
Payout Ratio: $0.00
Current Ratio: $1.78

Source	Headline
	Figma shares rise as Bank of America resumes coverage with a ‘Buy’ rating Figma (NYSE:FIG) was reinstated with a ‘Buy’ rating and a $30 price objective by Bank of America, with the firm arguing that artificial intelligence is... proactiveinvestors.com - 2026-07-07 12:02:00
	Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) is raising about A$11.12 million before costs through a two-tranche placement, strengthening its balance sheet as... proactiveinvestors.com - 2026-07-07 07:36:00
	Shell flags 'significantly higher' gas trading and sells South Africa business - UPDATE Shell PLC (LSE:SHEL, NYSE:SHEL) shares jumped over 2% after it said stronger trading and improved refining margins should support second-quarter... proactiveinvestors.com - 2026-07-07 04:38:00
	Imugene reports second BTKi cohort response - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF) earlier this week reported a second complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or BTKi, cohort... proactiveinvestors.com - 2026-07-04 06:00:00
	Imugene CEO details azer-cel trial milestone - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or... proactiveinvestors.com - 2026-07-03 06:41:00
	Anthropic clears export hurdle for Fable 5, easing a threat to its IPO story The most striking thing about the standoff that ended on Tuesday is not that it ended, but that it happened at all: a US government blocking a US company... proactiveinvestors.com - 2026-07-01 07:10:00
	Imugene reports second complete response in azer-cel BTKi cohort Just a day after reporting the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its ongoing Phase 1b azer-cel... proactiveinvestors.com - 2026-07-01 06:59:00
	Fed may adopt leaner communications strategy under Warsh, says Deutsche Bank Federal Reserve communications are likely to become shorter, less reliant on forward guidance and more focused on longer-term economic narratives under new... proactiveinvestors.com - 2026-07-01 06:00:00
	Nasdaq leads Wall Street higher, Dow Jones notches new record as second quarter ends 4:15pm: Best quarter since 2020 Wall Street has wrapped up its best quarter since 2020, with the Dow Jones adding another 0.3% on Friday to close at a fresh... proactiveinvestors.com - 2026-06-30 12:15:00
	Imugene reports first complete response in azer-cel BTKi cohort Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its... proactiveinvestors.com - 2026-06-30 08:27:00
	FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week announced that the US Food and Drug Administration (FDA) granted Fast Track Designation to its... proactiveinvestors.com - 2026-06-12 06:38:00
	Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions CAR T therapies have transformed treatment options for some blood cancers. They have also exposed one of cell therapy's biggest practical limitations: time.... proactiveinvestors.com - 2026-06-09 10:32:00
	Thor Energy lifted by hydrogen project update Thor Energy PLC (AIM:THR, OTCQB:THORF, ASX:THR) shares lifted 25%, to 0.75p, after it said Phase-2 survey work at its HY-Range project in South Australia... proactiveinvestors.com - 2026-06-09 06:14:00
	Imugene showcases Azer-Cel progress at ASCO - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week highlighted encouraging clinical progress for its Azer-Cel program after presenting new data at... proactiveinvestors.com - 2026-06-05 07:07:00
	Dow Jones, Nasdaq close at record levels as Trump says US-Iran peace talks are advancing 4:15pm: Peace optimism boosts stocks US stocks finished Monday’s session higher on renewed hopes a peace deal would be struck between the US and Iran, with... proactiveinvestors.com - 2026-06-01 12:15:00
	Costco's value strategy, membership growth support outlook after strong quarter, says Jefferies Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) delivered a strong fiscal third quarter performance, with its value-focused strategy, membership... proactiveinvestors.com - 2026-06-01 12:08:00
	Anthropic confidentially files to go public in the US Anthropic said on Monday it has confidentially filed for a US initial public offering, positioning the artificial intelligence company for what could become... proactiveinvestors.com - 2026-06-01 09:12:00
	Iovance Biotherapeutics pushes cell therapy platform into solid tumor market Iovance Biotherapeutics (NASDAQ:IOVA) said it has obtained clearance of an Investigational New Drug application for IOV-5001, extending its next-generation... proactiveinvestors.com - 2026-06-01 08:29:00
	Small Cap Watch: commercial expansion updates drive news flow The S&P/ASX Small Ordinaries Index continued its strong run, climbing 2.28% on Friday to close at 3,501.80 and gaining 2.19% over the past five trading... proactiveinvestors.com - 2026-06-01 06:02:00
	Imugene presents azer-cel data at ASCO as trial expands into new cohort Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has presented new Phase 1b data for its azer-cel cell therapy at the 2026 American Society of Clinical Oncology... proactiveinvestors.com - 2026-06-01 05:50:00
	Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) recently highlighted encouraging new clinical data for its allogeneic CAR-T therapy Azer-Cel, while also... proactiveinvestors.com - 2026-05-29 06:50:00
	Costco reports strong sales growth in fiscal third quarter Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) reported fiscal third quarter financial results that topped Wall Street expectations, though shares... proactiveinvestors.com - 2026-05-28 12:41:00
	Imugene doses first patient in BTKi combination cohort for azer-cel study Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has dosed the first patient in the Bruton Tyrosine Kinase inhibitor (BTKi) combination cohort of its Phase 1b... proactiveinvestors.com - 2026-05-28 07:14:00
	Imugene strengthens board with biotech and pharma appointments Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has appointed Dr Charmaine Gittleson and Michael Kotsanis as non-executive directors as part of a board... proactiveinvestors.com - 2026-05-26 07:29:00
	IBM shares extend rally as Wedbush calls US quantum investment a "new catalyst" International Business Machines Corp (NYSE:IBM) shares are on track to close the week nearly 18% higher after the US Department of Commerce's $2 billion... proactiveinvestors.com - 2026-05-22 08:20:00
	Diamond Equity Research Releases Update Note on Imugene Limited (ASX: IMU) New York, May 20, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Imugene Ltd. (ASX: IMU) resuming coverage. The research summary below is from a report commissioned by Imugene Ltd. and produced by Diamond Equity Research. The in-depth 24-page update note includes detailed information on the Imugene's business model, industry, financial results, and risks. globenewswire.com - 2026-05-20 08:00:00
	Imugene valuation points to 129% upside as broker backs azer-cel strategy Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) could be significantly undervalued as its focused push into allogeneic CAR-T therapy gathers momentum, according... proactiveinvestors.com - 2026-05-13 08:18:00